| __timestamp | ACADIA Pharmaceuticals Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 3243000 |
| Thursday, January 1, 2015 | 76369000 | 2472000 |
| Friday, January 1, 2016 | 4406000 | 2548000 |
| Sunday, January 1, 2017 | 13060000 | 19623000 |
| Monday, January 1, 2018 | 18330000 | 30421000 |
| Tuesday, January 1, 2019 | 19598000 | 32793999 |
| Wednesday, January 1, 2020 | 20550000 | 28304000 |
| Friday, January 1, 2021 | 19141000 | 620000 |
| Saturday, January 1, 2022 | 10166000 | 755000 |
| Sunday, January 1, 2023 | 45731000 | 1322000 |
Cracking the code
In the ever-evolving landscape of biotechnology, understanding cost dynamics is crucial. ACADIA Pharmaceuticals Inc. and Viridian Therapeutics, Inc. offer a fascinating case study in cost of revenue trends from 2014 to 2023. ACADIA's cost of revenue peaked in 2015, reaching nearly 76 million, before experiencing a significant decline, dropping by over 80% by 2022. In contrast, Viridian's costs surged dramatically, with a notable spike in 2019, reaching over 32 million, before plummeting to just 620,000 in 2021. This stark contrast highlights the volatile nature of the biotech industry, where strategic shifts and market conditions can lead to rapid changes in financial metrics. As investors and analysts look to the future, these trends underscore the importance of agility and innovation in maintaining competitive advantage.
Cost of Revenue: Key Insights for GSK plc and Viridian Therapeutics, Inc.
Neurocrine Biosciences, Inc. vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Incyte Corporation and ACADIA Pharmaceuticals Inc.'s Expenses
BioMarin Pharmaceutical Inc. vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Halozyme Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.
Amneal Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
ACADIA Pharmaceuticals Inc. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: ACADIA Pharmaceuticals Inc. vs Evotec SE
Comparing Cost of Revenue Efficiency: HUTCHMED (China) Limited vs Viridian Therapeutics, Inc.
Geron Corporation vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored